Best Oral GLP-1 Tablet & ODT Providers in 2026 — Ranked & Reviewed
Injectable vials are what most compounded GLP-1 providers ship. A growing minority also sell oral formulations: oral dissolving tablets (ODT), sublingual tablets, or other non-injectable routes. Be clear about the evidence gap before you switch. Nothing equivalent to the STEP or SURMOUNT randomized trials has been run on oral compounded semaglutide or tirzepatide, so the evidence base is weaker than for the FDA-approved injectables. Lilly's Foundayo (orforglipron) holds the only FDA approval for an oral GLP-1 in weight loss, and it rests on an entirely different small-molecule chemistry. A needle-averse patient who accepts that weaker evidence base can still make a reasonable choice here. Every provider on the register offering an oral compounded GLP-1, whether alongside injectables or instead of them, is ranked below, with the form factor and the quality of the evidence noted for each.
Lowest verified price: $79/mo79 providers compared
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
79 oral glp-1 tablet & odt providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
knowing which pharmacy fills the vial — it names RedRock Pharmacy
From /mo$79Coverage50 statesMedicationsSemaglutideTirzepatide semaglutide at $99/month, 48% under the register median
From /mo$99Coverage49 statesMedicationsSemaglutideTirzepatide- Nationwide Coverage
bloodwork inside the $179/month rather than billed on top
From /mo$179Coverage50 statesMedicationsSemaglutideTirzepatide semaglutide at $119/month, 55% under the register median
From /mo$119CoverageCheck intakeMedicationsSemaglutideTirzepatide- Best Budget
starting below a standard dose, with microdose tiers
From /mo$49CoverageCheck intakeMedicationsSemaglutideTirzepatide an oral route if you will not self-inject
From /mo$49Coverage45 statesMedicationsSemaglutideTirzepatidesemaglutide at $125/month, 34% under the register median
From /mo$125Scales with doseCoverageCheck intakeMedicationsSemaglutideTirzepatidestarting below a standard dose, with microdose tiers
From /mo$79CoverageCheck intakeMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick knowing which pharmacy fills the vial — it names RedRock Pharmacy | $79 | SemaglutideTirzepatide | 50 states | Visit → | |
 semaglutide at $99/month, 48% under the register median | $99 | SemaglutideTirzepatide | 49 states | Visit → | |
Nationwide Coverage bloodwork inside the $179/month rather than billed on top | $179 | SemaglutideTirzepatide | 50 states | Visit → | |
 semaglutide at $119/month, 55% under the register median | $119 | SemaglutideTirzepatide | Check intake | Visit → | |
Best Budget starting below a standard dose, with microdose tiers | $49 | SemaglutideTirzepatide | Check intake | Visit → | |
 an oral route if you will not self-inject | $49 | SemaglutideTirzepatide | 45 states | Visit → | |
 semaglutide at $125/month, 34% under the register median | $125 Scales by dose | SemaglutideTirzepatide | Check intake | Visit → | |
 starting below a standard dose, with microdose tiers | $79 | SemaglutideTirzepatide | Check intake | Visit → |
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
Detailed Reviews
Embody
Best for: knowing which pharmacy fills the vial — it names RedRock Pharmacy
Embody sells compounded semaglutide and tirzepatide by injection, plus a compounded oral tirzepatide gum that is unique in the category. Flat-rate pricing is aggressive, coverage runs to all 50 states, and clinician messaging is available 24/7 under a board-certified internal medicine CMO.
Score Breakdown
Pros
- ✓Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $129 a month, 52% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for all 50 states
- ✓Names 4 dispensing pharmacies, which most sellers in this register do not do
- ✓No FDA warning letter matched this operator when we searched our enforcement register
- ✓Both oral and injectable options are on record, so the format is a choice rather than a condition
Cons
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Strut Health
Verified partnerBest for: semaglutide at $99/month, 48% under the register median
Strut Health sells LegitScript and ACHC-accredited compounded semaglutide and tirzepatide in injectable and oral lozenge formats, shipping to 49 states. Board-certified US physicians handle prescribing and follow-up messaging is unlimited and free. Eligibility is gated behind a clinician determination of medical necessity that the company does not publicly define.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓Coverage is published for 49 states
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗1 FDA warning letter matched to this operator in our enforcement register — read what the letter alleges, since a letter discloses a problem rather than disqualifying a seller
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Vaylen
Best for: bloodwork inside the $179/month rather than billed on top
Vaylen is a pure GLP-1 specialist: compounded semaglutide at $179/mo, compounded tirzepatide at $239/mo, a compounded oral GLP-1 at $259/mo, and brand-name Ozempic, Zepbound, and Wegovy. LegitScript certified, with licensed clinicians in all 50 states.
Score Breakdown
Pros
- ✓Semaglutide at $179 a month, within the normal band around this register's $189 median for the same drug and form
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping, labs, coaching
- ✓Coverage is published for all 50 states
- ✓No FDA warning letter matched this operator when we searched our enforcement register
- ✓Baseline bloodwork is required before a prescription
Cons
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Fitness RX
Best for: semaglutide at $119/month, 55% under the register median
Fitness RX charges $119/mo, and that figure carries the medication, 1:1 physician consults and messaging without limit; an intro promo takes $100 off for life. Its plan runs three phases and welds fitness and nutrition coaching onto the drug. Both GLP-1 routes are sold, compounded injectable and sublingual semaglutide or tirzepatide, and brand-name Wegovy and Zepbound. Terms, Privacy and data-privacy pages are up, with a link out to LegitScript verification that was not independently confirmed here. Neither the compounder nor the legal entity is identified. The site is fitnessrx.com.
Score Breakdown
Pros
- ✓Semaglutide at $119 a month, 37% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $119 a month, 55% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓No FDA warning letter matched this operator when we searched our enforcement register
Cons
- ✗No state list is on record here, so whether it serves your state cannot be confirmed from this page
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Telos Rx
Verified partnerBest for: starting below a standard dose, with microdose tiers
Read the $49 headline at Telos Rx carefully: it is a first-month intro rate and the standing cost sits above it. Superior Health Solutions LLC operates the platform, which sells GLP-1 weight loss beside longevity, recovery and sexual-health peptides. Compounded semaglutide and tirzepatide come as injections, or as needle-free sublinguals, with a microdosed tirzepatide too. Providers adjust doses, labs are monitored, delivery is free and discreet, FSA/HSA works and canceling is open. Compounded drugs are not FDA-approved. No pharmacy, no state list, no LegitScript.
Score Breakdown
Pros
- ✓Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- ✓Tirzepatide at $139 a month, 48% below the $267 median for the same drug and form across this register
- ✓Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- ✓The monthly figure covers medication, consult, shipping
- ✓No FDA warning letter matched this operator when we searched our enforcement register
- ✓Both oral and injectable options are on record, so the format is a choice rather than a condition
Cons
- ✗No state list is on record here, so whether it serves your state cannot be confirmed from this page
- ✗No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Comparing sellers of oral GLP-1s
Two pills qualify: orforglipron, sold as Foundayo, and oral semaglutide, sold as Rybelsus and as oral Wegovy. Both trade some effectiveness for skipping the needle. What matters is that a prescriber writes for an FDA-approved pill, since the shelves also carry over-the-counter GLP-1 products with no evidence behind them.
What to check
- A drug rather than a supplement. Orforglipron and oral semaglutide are the oral GLP-1 medications that exist. Anything labeled 'GLP-1 support' and sold without a prescription is not one of them, whatever the packaging implies. Confirm that the prescription product is what ships.
- The dosing rules differ by pill. Oral semaglutide requires an empty stomach and strict water timing. Orforglipron carries no food restriction. One fits a given routine better than the other, and a seller that never explains the protocol leaves the buyer to find out.
- How the pill is set against the injection. Injections generally produce more weight loss than pills do. Sellers that say so are describing the evidence. A page presenting its pill as a match for injectables, or an improvement on them, is doing something else.
Red flags
- Pharmacy unnamed and no LegitScript listing. Two disclosures are checkable on any compounded-GLP-1 seller: the 503A or 503B pharmacy filling the vial, and a LegitScript certification. When a site publishes neither, nothing about the contents of that vial can be confirmed from outside.
- Instant approval with no clinician you can reach. A prescriber is supposed to read the intake and stay available once dose questions start. Approval issued automatically, with nobody reachable afterward, means the medical layer was removed rather than streamlined.
- The advertised number is a first month. Headline figures here are usually qualified somewhere. Common forms are an opening rate that steps up with each dose increase, and a membership fee billed separately from the drug itself. Either one can double what leaves your account in month two.
- B12, MIC, or HCG sold for weight loss. Trial evidence for weight loss sits with the GLP-1 injections and nowhere else on this aisle. A clinic that lists lipotropic, B12, or HCG shots under weight loss is selling past the record, whatever its own site says.
Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.